Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Medicare Panel Looks To Upcoming Study To Fill Evidence Gaps For Carotid Artery Disease

This article was originally published in The Gray Sheet

Executive Summary

There's a lot more to learn about which treatment to choose for carotid atherosclerosis patients, Medicare advisors said this week. A new trial in the works that would compare both surgery and stenting to standalone medical therapy presents a good opportunity to fill the gaps.

You may also be interested in...



Research In Brief

Data from annual gatherings of the Society of Thoracic Surgeons and the American Stroke Association, and more.

News In Brief

Abbott’s RX Acculink

New Guidelines Give Near-Equal Measure To Carotid Stenting And Surgery

Carotid stenting is a viable alternative to surgery for patients at risk for stroke due to clogged neck arteries, according to new guidelines issued Jan. 31 by 14 neuroscience, cardiology and surgical specialty societies.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT030921

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel